David D O'Toole Avita Medical, Inc. (RCEL) insider trading activity

David D O'Toole is CFO of AVITA Medical, Inc.. Currently has a direct ownership of 31,657 shares of RCEL, which is worth approximately $195,956. The most recent transaction as insider was on Aug 26, 2025, when has been sold 2,000 shares (Common Stock) at a price of $4.52 per share, resulting in proceeds of $9,040. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 31.7K

14.46% 3M change

44.07% 12M change

Total Value Held $195,956

David D O'Toole Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 26 2025	BUY Open market or private purchase	$9,040 $4.52 p/Share	2,000 Added 5.94%	31,657 Common Stock
Aug 12 2025	BUY Open market or private purchase	$9,620 $4.81 p/Share	2,000 Added 6.32%	29,657 Common Stock
May 30 2025	BUY Grant, award, or other acquisition	$9,191 $4.78 p/Share	1,923 Added 6.5%	27,657 Common Stock
Feb 20 2025	BUY Open market or private purchase	$9,900 $9.9 p/Share	1,000 Added 3.74%	25,734 Common Stock
Feb 19 2025	BUY Open market or private purchase	$10,250 $10.25 p/Share	1,000 Added 3.89%	24,734 Common Stock
Dec 05 2024	BUY Open market or private purchase	$12,158 $12.47 p/Share	975 Added 3.95%	23,734 Common Stock
Nov 29 2024	BUY Grant, award, or other acquisition	$6,146 $7.83 p/Share	785 Added 3.33%	22,759 Common Stock
May 31 2024	BUY Grant, award, or other acquisition	$18,300 $8.17 p/Share	2,240 Added 9.25%	21,974 Common Stock
May 30 2024	BUY Open market or private purchase	$8,900 $8.9 p/Share	1,000 Added 4.82%	19,734 Common Stock
Feb 28 2024	BUY Open market or private purchase	$21,762 $17.41 p/Share	1,250 Added 6.26%	18,734 Common Stock
Dec 12 2023	BUY Open market or private purchase	$11,827 $12.45 p/Share	950 Added 5.15%	17,484 Common Stock
Dec 01 2023	BUY Open market or private purchase	$5,340 $10.68 p/Share	500 Added 2.94%	16,534 Common Stock
Nov 30 2023	BUY Grant, award, or other acquisition	$9,368 $9.06 p/Share	1,034 Added 6.06%	16,034 Common Stock
Nov 21 2023	BUY Open market or private purchase	$20,560 $10.28 p/Share	2,000 Added 11.76%	15,000 Common Stock
Nov 16 2023	BUY Open market or private purchase	$12,150 $12.15 p/Share	1,000 Added 7.69%	12,000 Common Stock
Nov 15 2023	BUY Open market or private purchase	$12,450 $12.45 p/Share	1,000 Added 7.14%	13,000 Common Stock
Nov 15 2023	BUY Open market or private purchase	$13,250 $13.25 p/Share	1,000 Added 8.33%	11,000 Common Stock
Nov 14 2023	BUY Open market or private purchase	$12,880 $12.88 p/Share	1,000 Added 9.09%	10,000 Common Stock
Aug 16 2023	BUY Open market or private purchase	$34,100 $17.05 p/Share	2,000 Added 18.18%	9,000 Common Stock
Aug 15 2023	BUY Open market or private purchase	$89,650 $17.93 p/Share	5,000 Added 41.67%	7,000 Common Stock
Jun 20 2023	BUY Open market or private purchase	$16,149 $16.15 p/Share	1,000 Added 33.33%	2,000 Common Stock

Also insider at

OPNT

OPIANT PHARMACEUTICALS, INC. Healthcare

Chief Financial Officer

DDO

David D O'Toole

CFO

Santa Monica, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RCEL shares.

Notify only if

Value

Insider Trading

Get notified when an Avita Medical, Inc. insider buys or sells RCEL shares.

Notify only if

Operation

Value

Type

News

Receive news related to AVITA Medical, Inc.

Track Activities on RCEL

Account